Last reviewed · How we verify

NCT05504044

To Study the Effects of Co-ingesting Different Forms of Almond, Almond Paste, Fibre, and Almond Phytochemicals With Bread on Postprandial Glucose and Insulin Profiles

Completed NA Last updated 31 August 2023
What this trial tests

NA trial testing Glucose control in Cardiovascular Diseases in 15 participants. Completed in 18 January 2023.

Timeline
25 October 2019
Primary endpoint
18 January 2023
18 January 2023

Quick facts

Lead sponsorSingapore Institute of Food and Biotechnology Innovation
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposebasic science
Enrollment15
Start date25 October 2019
Primary completion18 January 2023
Estimated completion18 January 2023
Sites1 location across Singapore

Drugs / interventions tested

Conditions studied

Sponsor

Singapore Institute of Food and Biotechnology Innovation

Who can join

Adults 21 to 60, male only, with Cardiovascular Diseases or Metabolic Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Food is emerging as the new medicine. There has been growing evidence of the beneficial effects of foods, including nuts on human health. Modulation of both glucose and insulin are at the heart of reducing the risk of cardiovascular and other metabolic diseases. The contribution that nuts have on human health has been studied extensively and it is well established that the consumption of nuts revealed improvements in both blood glucose profile and reduced the risk of coronary heart diseases. Nuts, such as almonds, are nutrient-dense foods that are particularly rich in a-tocopherol. They are excellent sources of protein (\~25% of energy) and fibre, low in saturated fatty acid content (4-6%) and high in monounsaturated fatty acids. They also contain significant amounts of essential micronutrients such as folate (B vitamin) and polyphenols. Recently, strong interests on the health effects of nuts improving metabolic syndrome and controlling diabetes has been reported. Preliminary studies have indicated that the inclusion of nuts in the diets of individuals with diabetes and/or metabolic syndrome may improve postprandial glycaemic response, and lipid metabolism in the long run.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Harnessing Nature's Toolbox: Naturally Derived Bioactive Compounds in Nanotechnology Enhanced Formulations.
    Sanjai C, Gaonkar SL, Hakkimane SS. · · 2024 · cited 10× · PMID 39494011 · DOI 10.1021/acsomega.4c07756
  2. Almond paste and dietary fibre: a novel way to improve postprandial glucose and lipid profiles?
    Bi X, Yeo MTY, Jeyakumar Henry C. · · 2022 · cited 1× · PMID 36329602 · DOI 10.1080/09637486.2022.2141207

Verify or expand the search:

Other recruiting trials for Cardiovascular Diseases

Currently open trials in the same condition.

Other Singapore Institute of Food and Biotechnology Innovation trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05504044.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing